Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Beck

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|March 12, 2021
Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation TreatmentCarmen Stromberger, Berna Yedikat, Annekatrin Coordes, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 14, 2012
Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosisCatherine J E Ingram, Michael E Weale, Christopher A Plaster, et al.
International Journal of Cancer|February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancerSebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Plos One|July 31, 2020
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patientsSebastian Zschaeck, Yimin Li, Qin Lin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 1, 2019
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancerMarcus Beck, Dirk Böhmer, Daniel M Aebersold, et al.
Scientific Reports|October 20, 2020
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.
Oral Oncology|June 3, 2025
Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis - A population-based study on German cancer registry dataChristian Doll, Elena Hofmann, Anna Trelinska-Finger, et al.
Radiation Oncology (London, England)|May 13, 2018
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectivesSebastian Zschaeck, Fabian Lohaus, Marcus Beck, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|March 12, 2021
Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation TreatmentCarmen Stromberger, Berna Yedikat, Annekatrin Coordes, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 14, 2012
Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosisCatherine J E Ingram, Michael E Weale, Christopher A Plaster, et al.
International Journal of Cancer|February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancerSebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Plos One|July 31, 2020
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patientsSebastian Zschaeck, Yimin Li, Qin Lin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 1, 2019
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancerMarcus Beck, Dirk Böhmer, Daniel M Aebersold, et al.
Scientific Reports|October 20, 2020
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.
Oral Oncology|June 3, 2025
Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis - A population-based study on German cancer registry dataChristian Doll, Elena Hofmann, Anna Trelinska-Finger, et al.
Radiation Oncology (London, England)|May 13, 2018
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectivesSebastian Zschaeck, Fabian Lohaus, Marcus Beck, et al.
Pageof 8